Radiation Research
New radiation research reported from Kyushu University
Published in Blood Weekly, September 2nd, 2010
Researchers detail in 'Concurrent chemoradiotherapy with S-1 for T2N0 glottic squamous cell carcinoma,' new data in radiation research. According to recent research from Japan, "In this study, we evaluated the feasibility, efficacy and toxicity of concurrent chemoradiotherapy with S-1 (tegafur-gimeracil-oteracil potassium) for T2N0 glottic carcinoma. A total of 23 patients with T2N0 glottic carcinoma received chemoradiotherapy with S-1."
"Radiotherapy consisted of five daily fractions of 2 Gy per week, to a total median dose of 70 Gy. S-1 was administered 65 mg/m2 per day for 4 weeks, beginning on the day therapy was started, followed by 2 weeks off the drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-09-02)
More Articles from Blood Weekly
- Health Services
Health care system delay may increase risk of death for heart patients receiving reperfusion therapy - Pancytopenia
New findings from University Medical Center describe advances in pancytopenia - Sepsis
Northwestern University, Department of Medicine publishes research in sepsis - Thrombocytopenic Purpura
Researchers from Children's University discuss findings in thrombocytopenic purpura - Aplastic Anemia
Chronic health conditions common for stem cell transplant survivors - Heart Attack
Data on heart attack published by researchers at University of Otago - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
